Bortezomib is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Reduced blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia, Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation
Bortezomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.
Bortezomib is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
Q. How does Bortezomib work?Bortezomib belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Q. Is Bortezomib FDA approved?Yes, Bortezomib is approved by FDA
Q. Is Bortezomib dialyzable?Yes, Bortezomib is dialyzable
Q. Is Bortezomib toxic?Bortezomib can cause toxic effects if not given in appropriate dose although not everybody gets them
Q. Does Bortezomib cause constipation?Bortezomib may cause side effects such as constipation.